Junshi Biosciences
Junshi Biosciences, officially known as Junshi Pharmaceutical Co., Ltd., is a leading biopharmaceutical company headquartered in China. Founded in 2012, the company has rapidly established itself in the global biotechnology landscape, focusing on the research, development, and commercialisation of innovative therapies, particularly in oncology and autoimmune diseases. With a strong presence in major operational regions including Asia and North America, Junshi Biosciences is recognised for its cutting-edge monoclonal antibody products. Notably, its flagship product, toripalimab, has garnered significant attention for its unique mechanism of action in cancer treatment. The company has achieved remarkable milestones, including successful partnerships and regulatory approvals, positioning itself as a key player in the biopharmaceutical industry.
DitchCarbon Score
How does Junshi Biosciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Junshi Biosciences's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Junshi Biosciences's reported carbon emissions
Junshi Biosciences, headquartered in China (CN), currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is unclear how they are addressing their carbon footprint. However, the company is likely aware of the growing importance of climate commitments within the biopharmaceutical industry. As the sector increasingly focuses on sustainability, Junshi Biosciences may be exploring initiatives to align with industry standards and expectations regarding carbon emissions reduction. Further information on their climate strategies or commitments would be necessary to provide a comprehensive overview of their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Junshi Biosciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
